Repligen Corp
NASDAQ:RGEN
Repligen Corp
NASDAQ:RGEN
Price:
158.36 USD
-3.56%
Market Closed
Updated:
May 2, 2024
Repligen Corp
Cash from Financing Activities
|
Repligen Corp
Cash from Financing Activities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Repligen Corp
NASDAQ:RGEN
|
Cash from Financing Activities
$249m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
136%
|
CAGR 10-Years
58%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Financing Activities
-$3.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Danaher Corp
NYSE:DHR
|
Cash from Financing Activities
-$144m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Financing Activities
-$859.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Financing Activities
-$382m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
See Also
What is Repligen Corp's Cash from Financing Activities?
Cash from Financing Activities
249m
USD
249m
USD
Based on the financial report for Dec 31, 2023, Repligen Corp's Cash from Financing Activities amounts to 249m USD.
What is Repligen Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
58%
58%
The average annual Cash from Financing Activities growth rates for Repligen Corp have been -7% over the past three years , 136% over the past five years , and 58% over the past ten years .
You don't have any saved screeners yet
